Literature DB >> 9688561

Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells.

C Arar1, J C Gaudin, L Capron, A Legrand.   

Abstract

The galectin-3 gene (LGALS3) encodes a beta-galactose binding lectin. LGALS3 expression is associated with neoplastic transformation and with differentiation of monocytes to macrophages. Factors involved in migration, proliferation, adhesion and differentiation of vascular smooth muscle cells (SMC) play a major role during atherosclerosis development. Expression of the galectin-3 gene was not detected in quiescent SMC but was activated in aortas of hypercholesterolemic rabbits, in aortas of rats after balloon injury and in cultured SMC. These results suggest that galectin-3 production is involved in the developmental process of atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688561     DOI: 10.1016/s0014-5793(98)00683-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

2.  Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.

Authors:  Scott A Barman; Zsuzsanna Bordan; Robert Batori; Stephen Haigh; David J R Fulton
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.

Authors:  Scott A Barman; Xueyi Li; Stephen Haigh; Dmitry Kondrikov; Keyvan Mahboubi; Zsuzsanna Bordan; David W Stepp; Jiliang Zhou; Yusi Wang; Daniel S Weintraub; Peter Traber; William Snider; Danny Jonigk; Jennifer Sullivan; G Ryan Crislip; Joshua T Butcher; Jennifer Thompson; Yunchao Su; Feng Chen; David J R Fulton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-06       Impact factor: 5.464

4.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

5.  Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study.

Authors:  Ana Djordjevic; Maja Zivkovic; Aleksandra Stankovic; Ivan Zivotic; Igor Koncar; Lazar Davidovic; Dragan Alavantic; Tamara Djuric
Journal:  J Clin Lab Anal       Date:  2016-05-21       Impact factor: 2.352

6.  Serum galectin-3 levels in women with PCOS.

Authors:  H Yilmaz; H T Celik; O Ozdemir; D Kalkan; M Namuslu; S Abusoglu; C R Atalay; R Yigitoglu
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

7.  Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells.

Authors:  Lei Tian; Kan Chen; Jiatian Cao; Zhihua Han; Lin Gao; Yue Wang; Yuqi Fan; Changqian Wang
Journal:  Mol Med Rep       Date:  2015-07-13       Impact factor: 2.952

8.  Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Alison C MacKinnon; Xiaojun Liu; Patrick Wf Hadoke; Mark R Miller; David E Newby; Tariq Sethi
Journal:  Glycobiology       Date:  2013-02-19       Impact factor: 4.313

9.  Spatial and temporal expression, and statin responsiveness of galectin-1 and galectin-3 in murine atherosclerosis.

Authors:  Yong-Jin Lee; Yoon-Seok Koh; Hyo Eun Park; Hee Jung Lee; Byung-Hee Hwang; Min-Kyu Kang; So-Young Lee; Pum-Joon Kim; Sang-Hyun Ihm; Ki-Bae Seung; Kiyuk Chang
Journal:  Korean Circ J       Date:  2013-04-30       Impact factor: 3.243

10.  Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis.

Authors:  Julio Madrigal-Matute; Jes Sandal Lindholt; Carlos Ernesto Fernandez-Garcia; Alberto Benito-Martin; Elena Burillo; Guillermo Zalba; Oscar Beloqui; Patricia Llamas-Granda; Alberto Ortiz; Jesus Egido; Luis Miguel Blanco-Colio; Jose Luis Martin-Ventura
Journal:  J Am Heart Assoc       Date:  2014-08-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.